Exact Mass: 460.22833260000004
Exact Mass Matches: 460.22833260000004
Found 500 metabolites which its exact mass value is equals to given mass value 460.22833260000004
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(6R)-6-(2-Hydroxy-2-methylpropyl)-3-[(1R)-1-[4-(1-methyl-2-oxopyridin-4-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one
3-Cyclobutene-1,2-dione, 3-((3-(3-(4-(5-methoxy-4-pyrimidinyl)-1-piperazinyl)propyl)-1H-indol-5-yl)amino)-4-methyl-
C25H28N6O3 (460.22227780000003)
(2S)-2,6,10,14-tetramethylpentadeca-1,18-diyl sulfate
1beta,3beta,6alpha-trihydroxy-4alpha(15)-dihydrocostic acid methyl ester-1-O-beta-glucopyranoside
(10R,11S,12R)-12-butoxy-11,12-dihydro-6,6,10,11-tetramethyl-4-phenyl-2H,6H,10H-dipyrano[2,3-f:2,3-h]chromen-2-one|12-O-butylinophyllum D
7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-(3-(trifluoromethyl)phenyl)pentyl)cyclopentyl)heptanoic acid
C24H35F3O5 (460.24364560000004)
Ala Lys Asn Glu
Ala Asp Lys Gln
Ala Asp Gln Lys
Ala Glu Glu Ile
Ala Glu Glu Leu
Ala Glu Ile Glu
Ala Glu Lys Asn
Ala Glu Leu Glu
Ala Glu Asn Lys
Ala Gly Lys Trp
Ala Gly Trp Lys
Ala His His Pro
Ala His Pro His
Ala Ile Glu Glu
Ala Lys Asp Gln
Ala Lys Glu Asn
Ala Lys Gly Trp
Ala Lys Gln Asp
Ala Lys Trp Gly
Ala Leu Glu Glu
Ala Asn Glu Lys
Ala Asn Lys Glu
Ala Asn Arg Thr
Ala Asn Thr Arg
Ala Pro His His
Ala Gln Asp Lys
Ala Gln Lys Asp
Ala Gln Arg Ser
Ala Gln Ser Arg
Ala Arg Asn Thr
Ala Arg Gln Ser
Ala Arg Ser Gln
Ala Arg Thr Asn
Ala Ser Gln Arg
Ala Ser Arg Gln
Ala Thr Asn Arg
Ala Thr Arg Asn
Ala Trp Gly Lys
Ala Trp Lys Gly
Asp Ala Lys Gln
Asp Ala Gln Lys
Asp Asp Ile Val
Asp Asp Leu Val
Asp Asp Val Ile
Asp Asp Val Leu
Asp Glu Val Val
Asp Ile Asp Val
Asp Ile Val Asp
Asp Lys Ala Gln
Asp Lys Gln Ala
Asp Leu Asp Val
Asp Leu Val Asp
Asp Gln Ala Lys
Asp Gln Lys Ala
Asp Val Asp Ile
Asp Val Asp Leu
Asp Val Glu Val
Asp Val Ile Asp
Asp Val Leu Asp
Asp Val Val Glu
Glu Ala Glu Ile
Glu Ala Glu Leu
Glu Ala Ile Glu
Glu Ala Lys Asn
Glu Ala Leu Glu
Glu Ala Asn Lys
Glu Asp Val Val
Glu Glu Ala Ile
Glu Glu Ala Leu
Glu Glu Ile Ala
Glu Glu Leu Ala
Glu Gly Lys Gln
Glu Gly Gln Lys
Glu Ile Ala Glu
Glu Ile Glu Ala
Glu Lys Ala Asn
Glu Lys Gly Gln
Glu Lys Asn Ala
Glu Lys Gln Gly
Glu Leu Ala Glu
Glu Leu Glu Ala
Glu Asn Ala Lys
Glu Asn Lys Ala
Glu Gln Gly Lys
Glu Gln Lys Gly
Glu Val Asp Val
Glu Val Val Asp
Phe Pro Pro Thr
Phe Pro Thr Pro
Phe Thr Pro Pro
Gly Ala Lys Trp
Gly Ala Trp Lys
Gly Glu Lys Gln
Gly Glu Gln Lys
Gly Lys Ala Trp
Gly Lys Glu Gln
Gly Lys Gln Glu
Gly Lys Trp Ala
Gly Gln Glu Lys
Gly Gln Lys Glu
Gly Gln Arg Thr
Gly Gln Thr Arg
Gly Arg Gln Thr
Gly Arg Thr Gln
Gly Thr Gln Arg
Gly Thr Arg Gln
Gly Trp Ala Lys
Gly Trp Lys Ala
His Ala His Pro
His Ala Pro His
His His Ala Pro
His His Pro Ala
His Pro Ala His
His Pro His Ala
Ile Ala Glu Glu
Ile Asp Asp Val
Ile Asp Val Asp
Ile Glu Ala Glu
Ile Glu Glu Ala
Ile Met Pro Thr
Ile Met Thr Pro
Ile Asn Asn Thr
Ile Asn Gln Ser
Ile Asn Ser Gln
Ile Asn Thr Asn
Ile Pro Met Thr
Ile Pro Thr Met
Ile Gln Asn Ser
Ile Gln Ser Asn
Ile Ser Asn Gln
Ile Ser Gln Asn
Ile Thr Met Pro
Ile Thr Asn Asn
Ile Thr Pro Met
Ile Val Asp Asp
Lys Ala Asp Gln
Lys Ala Glu Asn
Lys Ala Gly Trp
Lys Ala Asn Glu
Lys Ala Gln Asp
Lys Ala Trp Gly
Lys Asp Ala Gln
Lys Asp Gln Ala
Lys Glu Ala Asn
Lys Glu Gly Gln
Lys Glu Asn Ala
Lys Glu Gln Gly
Lys Gly Ala Trp
Lys Gly Glu Gln
Lys Gly Gln Glu
Lys Gly Trp Ala
Lys Asn Ala Glu
Lys Asn Glu Ala
Lys Gln Ala Asp
Lys Gln Asp Ala
Lys Gln Glu Gly
Lys Gln Gly Glu
Lys Trp Ala Gly
Lys Trp Gly Ala
Leu Ala Glu Glu
Leu Asp Asp Val
Leu Asp Val Asp
Leu Glu Ala Glu
Leu Glu Glu Ala
Leu Met Pro Thr
Leu Met Thr Pro
Leu Asn Asn Thr
Leu Asn Gln Ser
Leu Asn Ser Gln
Leu Asn Thr Asn
Leu Pro Met Thr
Leu Pro Thr Met
Leu Gln Asn Ser
Leu Gln Ser Asn
Leu Ser Asn Gln
Leu Ser Gln Asn
Leu Thr Met Pro
Leu Thr Asn Asn
Leu Thr Pro Met
Leu Val Asp Asp
Met Ile Pro Thr
Met Ile Thr Pro
Met Leu Pro Thr
Met Leu Thr Pro
Met Pro Ile Thr
Met Pro Leu Thr
Met Pro Thr Ile
Met Pro Thr Leu
Met Thr Ile Pro
Met Thr Leu Pro
Met Thr Pro Ile
Met Thr Pro Leu
Asn Ala Glu Lys
Asn Ala Lys Glu
Asn Ala Arg Thr
Asn Ala Thr Arg
Asn Glu Ala Lys
Asn Glu Lys Ala
Asn Ile Asn Thr
Asn Ile Gln Ser
Asn Ile Ser Gln
Asn Ile Thr Asn
Asn Lys Ala Glu
Asn Lys Glu Ala
Asn Leu Asn Thr
Asn Leu Gln Ser
Asn Leu Ser Gln
Asn Leu Thr Asn
Asn Asn Ile Thr
Asn Asn Leu Thr
Asn Asn Thr Ile
Asn Asn Thr Leu
Asn Gln Ile Ser
Asn Gln Leu Ser
Asn Gln Ser Ile
Asn Gln Ser Leu
Asn Gln Thr Val
Asn Gln Val Thr
Asn Arg Ala Thr
Asn Arg Thr Ala
Asn Ser Ile Gln
Asn Ser Leu Gln
Asn Ser Gln Ile
Asn Ser Gln Leu
Asn Thr Ala Arg
Asn Thr Ile Asn
Asn Thr Leu Asn
Asn Thr Asn Ile
Asn Thr Asn Leu
Asn Thr Gln Val
Asn Thr Arg Ala
Asn Thr Val Gln
Asn Val Gln Thr
Asn Val Thr Gln
Pro Ala His His
Pro Phe Pro Thr
Pro Phe Thr Pro
Pro His Ala His
Pro His His Ala
Pro Ile Met Thr
Pro Ile Thr Met
Pro Leu Met Thr
Pro Leu Thr Met
Pro Met Ile Thr
Pro Met Leu Thr
Pro Met Thr Ile
Pro Met Thr Leu
Pro Pro Phe Thr
Pro Pro Thr Phe
Pro Thr Phe Pro
Pro Thr Ile Met
Pro Thr Leu Met
Pro Thr Met Ile
Pro Thr Met Leu
Pro Thr Pro Phe
Gln Ala Asp Lys
Gln Ala Lys Asp
Gln Ala Arg Ser
Gln Ala Ser Arg
Gln Asp Ala Lys
Gln Asp Lys Ala
Gln Glu Gly Lys
Gln Glu Lys Gly
Gln Gly Glu Lys
Gln Gly Lys Glu
Gln Gly Arg Thr
Gln Gly Thr Arg
Gln Ile Asn Ser
Gln Ile Ser Asn
Gln Lys Ala Asp
Gln Lys Asp Ala
Gln Lys Glu Gly
Gln Lys Gly Glu
Gln Leu Asn Ser
Gln Leu Ser Asn
Gln Asn Ile Ser
Gln Asn Leu Ser
Gln Asn Ser Ile
Gln Asn Ser Leu
Gln Asn Thr Val
Gln Asn Val Thr
Gln Gln Ser Val
Gln Gln Val Ser
Gln Arg Ala Ser
Gln Arg Gly Thr
Gln Arg Ser Ala
Gln Arg Thr Gly
Gln Ser Ala Arg
Gln Ser Ile Asn
Gln Ser Leu Asn
Gln Ser Asn Ile
Gln Ser Asn Leu
Gln Ser Gln Val
Gln Ser Arg Ala
Gln Ser Val Gln
Gln Thr Gly Arg
Gln Thr Asn Val
Gln Thr Arg Gly
Gln Thr Val Asn
Gln Val Asn Thr
Gln Val Gln Ser
Gln Val Ser Gln
Gln Val Thr Asn
Arg Ala Asn Thr
Arg Ala Gln Ser
Arg Ala Ser Gln
Arg Ala Thr Asn
Arg Gly Gln Thr
Arg Gly Thr Gln
Arg Asn Ala Thr
Arg Asn Thr Ala
Arg Gln Ala Ser
Arg Gln Gly Thr
Arg Gln Ser Ala
Arg Gln Thr Gly
Arg Ser Ala Gln
Arg Ser Gln Ala
Arg Thr Ala Asn
Arg Thr Gly Gln
Arg Thr Asn Ala
Arg Thr Gln Gly
Ser Ala Gln Arg
Ser Ala Arg Gln
Ser Ile Asn Gln
Ser Ile Gln Asn
Ser Leu Asn Gln
Ser Leu Gln Asn
Ser Asn Ile Gln
Ser Asn Leu Gln
Ser Asn Gln Ile
Ser Asn Gln Leu
Ser Gln Ala Arg
Ser Gln Ile Asn
Ser Gln Leu Asn
Ser Gln Asn Ile
Ser Gln Asn Leu
Ser Gln Gln Val
Ser Gln Arg Ala
Ser Gln Val Gln
Ser Arg Ala Gln
Ser Arg Gln Ala
Ser Val Gln Gln
Thr Ala Asn Arg
Thr Ala Arg Asn
Thr Phe Pro Pro
Thr Gly Gln Arg
Thr Gly Arg Gln
Thr Ile Met Pro
Thr Ile Asn Asn
Thr Ile Pro Met
Thr Leu Met Pro
Thr Leu Asn Asn
Thr Leu Pro Met
Thr Met Ile Pro
Thr Met Leu Pro
Thr Met Pro Ile
Thr Met Pro Leu
Thr Asn Ala Arg
Thr Asn Ile Asn
Thr Asn Leu Asn
Thr Asn Asn Ile
Thr Asn Asn Leu
Thr Asn Gln Val
Thr Asn Arg Ala
Thr Asn Val Gln
Thr Pro Phe Pro
Thr Pro Ile Met
Thr Pro Leu Met
Thr Pro Met Ile
Thr Pro Met Leu
Thr Pro Pro Phe
Thr Gln Gly Arg
Thr Gln Asn Val
Thr Gln Arg Gly
Thr Gln Val Asn
Thr Arg Ala Asn
Thr Arg Gly Gln
Thr Arg Asn Ala
Thr Arg Gln Gly
Thr Val Asn Gln
Thr Val Gln Asn
Val Asp Asp Ile
Val Asp Asp Leu
Val Asp Glu Val
Val Asp Ile Asp
Val Asp Leu Asp
Val Asp Val Glu
Val Glu Asp Val
Val Glu Val Asp
Val Ile Asp Asp
Val Leu Asp Asp
Val Asn Gln Thr
Val Asn Thr Gln
Val Gln Asn Thr
Val Gln Gln Ser
Val Gln Ser Gln
Val Gln Thr Asn
Val Ser Gln Gln
Val Thr Asn Gln
Val Thr Gln Asn
Val Val Asp Glu
Val Val Glu Asp
Trp Ala Gly Lys
Trp Ala Lys Gly
Trp Gly Ala Lys
Trp Gly Lys Ala
Trp Lys Ala Gly
Trp Lys Gly Ala
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1&alpha
C24H35F3O5 (460.24364560000004)
4-[(1E,4E)-5-[4-(dimethylamino)phenyl]-3-(4-methylphenyl)sulfonylpenta-1,4-dienyl]-N,N-dimethylaniline
Taselisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Abediterol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
Gusacitinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Isometamidium
C28H26N7+ (460.22495760000004)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1alpha
C24H35F3O5 (460.24364560000004)
N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-[(5-methyl-2-furanyl)methylamino]-1-oxopropan-2-yl]cyclopropyl]-phenylmethyl]carbamic acid (phenylmethyl) ester
6-methoxy-3-[[2-oxolanylmethyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one
C25H28N6O3 (460.22227780000003)
N-[2-(diethylamino)-5-(4-morpholinylsulfonyl)phenyl]-2-[(phenylmethyl)amino]acetamide
2-[(3R,6aR,8S,10aR)-1-[1,3-benzodioxol-5-yl(oxo)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclopentylacetamide
2-[(3S,6aS,8R,10aS)-1-(1,3-benzodioxole-5-carbonyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclopentylacetamide
2-[(3R,6aR,8R,10aR)-1-(1,3-benzodioxole-5-carbonyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclopentylacetamide
(2S)-2-[(4R,5S)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H36N2O4S (460.23956560000005)
(2S)-2-[(4R,5R)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H36N2O4S (460.23956560000005)
(2R)-2-[(4S,5S)-4-methyl-8-(4-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H36N2O4S (460.23956560000005)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-[(3S,6aR,8S,10aR)-1-[1,3-benzodioxol-5-yl(oxo)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclopentylacetamide
cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyridinyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone
(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(2R)-2-[(4S,5R)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H36N2O4S (460.23956560000005)
(2R)-2-[(4R,5S)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H36N2O4S (460.23956560000005)
(2S)-2-[(4S,5R)-4-methyl-8-(2-methylphenyl)-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H36N2O4S (460.23956560000005)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(2-thiazolylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
2-[(3S,6aS,8S,10aS)-1-[1,3-benzodioxol-5-yl(oxo)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclopentylacetamide
cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-[oxo(2-pyridinyl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone
(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)
(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-4-[(4-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H29FN2O3 (460.21620959999996)